Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The Chemogenetic Receptor Ligand Clozapine N-Oxide Induces in vivo Neuroreceptor Occupancy and Reduces Striatal Glutamate Levels

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Microstate Changes Associated With Alzheimer's Disease in Persons With Down Syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Data-Driven Analysis of EEG Reveals Concomitant Superficial Sleep During Deep Sleep in Insomnia Disorder

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Genetic Overlap Between Alzheimer's Disease and Bipolar Disorder Implicates the MARK2 and VAC14 Genes

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Microstates as Disease and Progression Markers in Patients With Mild Cognitive Impairment

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Radiosynthesis and preclinical evaluation of [11 C]Cimbi-701 - Towards the imaging of cerebral 5-HT7 receptors

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. One-Step Synthesis of N-Succinimidyl-4-[18F]Fluorobenzoate ([18F]SFB)

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Development and Evaluation of Two Potential 5-HT7 Receptor PET Tracers: [18F]ENL09 and [18F]ENL10

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Multifunctional Clickable Reagents for Rapid Bioorthogonal Astatination and Radio-Crosslinking

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Chemogenetic studies with the ligand clozapine N-oxide (CNO) are predicated upon the assumption that CNO is devoid of actions at natural neuroreceptors. However, recent evidence shows that CNO may be converted back to clozapine (CLZ) in vivo, which could yield plasma concentrations that may be sufficient to occupy inter alia dopamine D2/3 and serotonin 5HT2A receptors in living brain. To test this phenomenon, we measured striatal dopamine D2/3 receptor occupancy with [18F]fallypride PET and serotonin 5HT2A occupancy ex vivo using [18F]MH.MZ. We found a CNO dose-dependent effect on the availability of both neuroreceptor sites. In parallel MR spectroscopy experiments, we found that CNO reduced creatine + phosphcreatine (Cr+PCr) and increased N-acetylaspartate + N-acetylaspartylglutamate (NAA+NAAG) signals in the prefrontal cortex, and also reduced the glutamate signal in dorsal striatum, with peak effect at 2 mg/kg. Thus, our findings suggest that conversion of CNO to CLZ in living rats imparts significant occupancy at endogenous neuroreceptors and significant changes to neurometabolite levels.

Original languageEnglish
JournalFrontiers in Neuroscience
Volume13
Pages (from-to)187
ISSN1662-4548
DOIs
Publication statusPublished - 2019

ID: 59056092